blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2190819

EP2190819 - QUATERNARY OPIOID CARBOXAMIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.03.2017
Database last updated on 31.08.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
RENSSELAER POLYTECHNIC INSTITUTE
J Bldg. 110 8th Street
Troy, NY 12180 / US
[2010/22]
Inventor(s)01 / WENTLAND, Mark, P.
4675 Telescope Avenue
Carlsbad, CA 92008 / US
 [2016/20]
Former [2010/22]01 / WENTLAND, Mark, P.
9 Dennin Drive
Menands, New York 12204 / US
Representative(s)Graf von Stosch, Andreas, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstraße 22
80538 München / DE
[2016/21]
Former [2010/22]Graf von Stosch, Andreas, et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Application number, filing date08797495.208.08.2008
[2010/22]
WO2008US72632
Priority number, dateUS20070954960P09.08.2007         Original published format: US 954960 P
[2010/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009023567
Date:19.02.2009
Language:EN
[2009/08]
Type: A1 Application with search report 
No.:EP2190819
Date:02.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 19.02.2009 takes the place of the publication of the European patent application.
[2010/22]
Type: B1 Patent specification 
No.:EP2190819
Date:25.05.2016
Language:EN
[2016/21]
Search report(s)International search report - published on:EP19.02.2009
ClassificationIPC:C07D221/26, C07D221/28, C07D489/00, A61K31/485
[2010/22]
CPC:
A61K31/485 (EP,NO,US); C07D221/28 (NO); A61P1/00 (EP);
A61P1/08 (EP); A61P1/10 (EP); A61P11/14 (EP);
A61P17/04 (EP); A61P25/04 (EP); A61P25/20 (EP);
A61P43/00 (EP); A61P7/10 (EP); C07D215/20 (EP,US);
C07D401/12 (EP,US); C07D405/06 (EP,US); C07D405/12 (EP,US);
C07D471/04 (EP,US); C07D487/08 (EP,US); C07D489/08 (EP,US);
C07D491/16 (EP,US); C07D491/22 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/21]
Former [2010/22]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL02.03.2010
BA02.03.2010
MK02.03.2010
RS02.03.2010
TitleGerman:QUATERNÄRE OPIATCARBOXAIMDE[2010/22]
English:QUATERNARY OPIOID CARBOXAMIDES[2010/22]
French:CARBOXAMIDES OPIOÏDES QUATERNAIRES[2010/22]
Entry into regional phase02.03.2010National basic fee paid 
02.03.2010Designation fee(s) paid 
02.03.2010Examination fee paid 
Examination procedure02.03.2010Amendment by applicant (claims and/or description)
02.03.2010Examination requested  [2010/22]
24.09.2010Despatch of a communication from the examining division (Time limit: M06)
21.03.2011Reply to a communication from the examining division
25.04.2012Despatch of a communication from the examining division (Time limit: M04)
07.05.2012Despatch of a communication from the examining division (Time limit: M04)
17.09.2012Reply to a communication from the examining division
14.04.2014Despatch of a communication from the examining division (Time limit: M06)
23.10.2014Reply to a communication from the examining division
09.11.2015Cancellation of oral proceeding that was planned for 24.11.2015
24.11.2015Date of oral proceedings (cancelled)
07.01.2016Communication of intention to grant the patent
13.04.2016Fee for grant paid
13.04.2016Fee for publishing/printing paid
13.04.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.09.2010
Opposition(s)28.02.2017No opposition filed within time limit [2017/18]
Fees paidRenewal fee
31.08.2010Renewal fee patent year 03
11.08.2011Renewal fee patent year 04
10.08.2012Renewal fee patent year 05
19.08.2013Renewal fee patent year 06
13.08.2014Renewal fee patent year 07
10.08.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.08.2008
AT25.05.2016
BG25.05.2016
CY25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
IS25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
TR25.05.2016
LU08.08.2016
NO25.08.2016
GR26.08.2016
MT31.08.2016
PT26.09.2016
[2018/38]
Former [2018/33]HU08.08.2008
AT25.05.2016
CY25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
IS25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
TR25.05.2016
LU08.08.2016
NO25.08.2016
GR26.08.2016
MT31.08.2016
PT26.09.2016
Former [2018/29]HU08.08.2008
AT25.05.2016
CY25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
TR25.05.2016
LU08.08.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2018/28]HU08.08.2008
AT25.05.2016
CY25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
LU08.08.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/37]AT25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
LU08.08.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/23]AT25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SI25.05.2016
SK25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/17]AT25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
MC25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SK25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/11]AT25.05.2016
CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SK25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/10]CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
PL25.05.2016
RO25.05.2016
SE25.05.2016
SK25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/09]CZ25.05.2016
DK25.05.2016
EE25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
RO25.05.2016
SE25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2017/07]DK25.05.2016
FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
SE25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2016/52]FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
SE25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2016/51]FI25.05.2016
HR25.05.2016
LT25.05.2016
LV25.05.2016
NO25.08.2016
GR26.08.2016
PT26.09.2016
Former [2016/49]FI25.05.2016
LT25.05.2016
NO25.08.2016
Former [2016/46]LT25.05.2016
NO25.08.2016
Cited inInternational search[X]GB874217  (ALBERT BOEHRINGER, et al) [X] 1 * pages 2-3; examples 1-11 *;
 [X]DE2254298  (BOEHRINGER SOHN INGELHEIM) [X] 1 * page 51; compound IX *;
 [A]US4032529  (WENTLAND MARK P, et al) [A] 2-28 * column 24; claim 1 *;
 [XD]US4176186  (GOLDBERG LEON I [US], et al) [XD] 1 * columns 3-7; examples 1-12 *;
 [X]WO9725331  (SMITHKLINE BEECHAM SPA [IT], et al) [X] 2-28 * page 10, line 9 * * page 42; claim 1 *;
 [X]ES2121553  (UNIV SANTIAGO COMPOSTELA [ES]) [X] 1 * page 4; compounds 13-16 *;
 [A]WO0236573  (RENSSELAER POLYTECH INST [US], et al) [A] 2-28 * page 35; claim 1 *;
 [X]US2005176645  (MICKLE TRAVIS [US], et al) [X] 1 * figure 1 *;
 [A]WO2007022535  (PHARMACOFORE INC [US], et al) [A] 2-28 * pages 75-77; claims 9-12; compounds IV-VII *;
 [A]  - WENTLAND M P ET AL, "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, (20050516), vol. 15, no. 10, ISSN 0960-894X, pages 2547 - 2551, XP004877722 [A] 2-28 * page 2547; figure 1 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2005.03.056
ExaminationUS6784187
by applicant   - RUSSELL ET AL., EUR./.PHARM., (1982), vol. 78, pages 255 - 61
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.